613 related articles for article (PubMed ID: 18563507)
1. Osteosarcoma development and stem cell differentiation.
Tang N; Song WX; Luo J; Haydon RC; He TC
Clin Orthop Relat Res; 2008 Sep; 466(9):2114-30. PubMed ID: 18563507
[TBL] [Abstract][Full Text] [Related]
2. A murine mesenchymal stem cell model for initiating events in osteosarcomagenesis points to CDK4/CDK6 inhibition as a therapeutic target.
Franceschini N; Gaeta R; Krimpenfort P; Briaire-de Bruijn I; Kruisselbrink AB; Szuhai K; Palubeckaitė I; Cleton-Jansen AM; Bovée JVMG
Lab Invest; 2022 Apr; 102(4):391-400. PubMed ID: 34921235
[TBL] [Abstract][Full Text] [Related]
3. Involvement of INK4A gene products in the pathogenesis and development of human osteosarcoma.
Benassi MS; Molendini L; Gamberi G; Magagnoli G; Ragazzini P; Gobbi GA; Sangiorgi L; Pazzaglia L; Asp J; Brantsing C; Picci P
Cancer; 2001 Dec; 92(12):3062-7. PubMed ID: 11753985
[TBL] [Abstract][Full Text] [Related]
4. Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines.
Park YB; Park MJ; Kimura K; Shimizu K; Lee SH; Yokota J
Cancer Genet Cytogenet; 2002 Mar; 133(2):105-11. PubMed ID: 11943335
[TBL] [Abstract][Full Text] [Related]
5. Biology of osteogenic sarcoma.
Wang LL
Cancer J; 2005; 11(4):294-305. PubMed ID: 16197719
[TBL] [Abstract][Full Text] [Related]
6. Heterozygous retinoblastoma gene mutation compromises in vitro osteogenesis of adipose mesenchymal stem cells - a temporal gene expression study.
Vincent A; Natarajan V; Khetan V; Krishnakumar S; Parameswaran S
Exp Cell Res; 2020 Nov; 396(1):112263. PubMed ID: 32890459
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathogenesis of osteosarcoma.
Kansara M; Thomas DM
DNA Cell Biol; 2007 Jan; 26(1):1-18. PubMed ID: 17263592
[TBL] [Abstract][Full Text] [Related]
8. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F; Rosu-Myles M; Menendez P; Rodriguez R
Stem Cells; 2014 May; 32(5):1136-48. PubMed ID: 24446210
[TBL] [Abstract][Full Text] [Related]
9. Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage.
Berman SD; Calo E; Landman AS; Danielian PS; Miller ES; West JC; Fonhoue BD; Caron A; Bronson R; Bouxsein ML; Mukherjee S; Lees JA
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11851-6. PubMed ID: 18697945
[TBL] [Abstract][Full Text] [Related]
10. The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development.
Rubio R; Gutierrez-Aranda I; Sáez-Castillo AI; Labarga A; Rosu-Myles M; Gonzalez-Garcia S; Toribio ML; Menendez P; Rodriguez R
Oncogene; 2013 Oct; 32(41):4970-80. PubMed ID: 23222711
[TBL] [Abstract][Full Text] [Related]
11. Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2.
Mohseny AB; Szuhai K; Romeo S; Buddingh EP; Briaire-de Bruijn I; de Jong D; van Pel M; Cleton-Jansen AM; Hogendoorn PC
J Pathol; 2009 Nov; 219(3):294-305. PubMed ID: 19718709
[TBL] [Abstract][Full Text] [Related]
12. The DNA helicase recql4 is required for normal osteoblast expansion and osteosarcoma formation.
Ng AJ; Walia MK; Smeets MF; Mutsaers AJ; Sims NA; Purton LE; Walsh NC; Martin TJ; Walkley CR
PLoS Genet; 2015 Apr; 11(4):e1005160. PubMed ID: 25859855
[TBL] [Abstract][Full Text] [Related]
13. RECQ DNA helicases and osteosarcoma.
Lu L; Jin W; Liu H; Wang LL
Adv Exp Med Biol; 2014; 804():129-45. PubMed ID: 24924172
[TBL] [Abstract][Full Text] [Related]
14. Generation of Osteosarcomas from a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem Cells.
Wang JY; Wu PK; Chen PC; Lee CW; Chen WM; Hung SC
Stem Cells Transl Med; 2017 Feb; 6(2):512-526. PubMed ID: 28191765
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma.
Tsuchiya T; Sekine K; Hinohara S; Namiki T; Nobori T; Kaneko Y
Cancer Genet Cytogenet; 2000 Jul; 120(2):91-8. PubMed ID: 10942797
[TBL] [Abstract][Full Text] [Related]
17. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
Nielsen GP; Burns KL; Rosenberg AE; Louis DN
Am J Pathol; 1998 Jul; 153(1):159-63. PubMed ID: 9665476
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer.
Sanchez-Cespedes M; Reed AL; Buta M; Wu L; Westra WH; Herman JG; Yang SC; Jen J; Sidransky D
Oncogene; 1999 Oct; 18(43):5843-9. PubMed ID: 10557071
[TBL] [Abstract][Full Text] [Related]
19. P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma development.
Velletri T; Xie N; Wang Y; Huang Y; Yang Q; Chen X; Chen Q; Shou P; Gan Y; Cao G; Melino G; Shi Y
Cell Death Dis; 2016 Jan; 7(1):e2015. PubMed ID: 26775693
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of genes of the Rb1 signalling pathway on osteosarcoma incidence and latency in alpha-particle irradiated mice.
Gonzalez-Vasconcellos I; Domke T; Kuosaite V; Esposito I; Sanli-Bonazzi B; Nathrath M; Atkinson MJ; Rosemann M
Radiat Environ Biophys; 2011 Mar; 50(1):135-41. PubMed ID: 21063720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
